YU195383A - Process for making biologicaly active tripeptide tetrapeptide alkylamide - Google Patents

Process for making biologicaly active tripeptide tetrapeptide alkylamide

Info

Publication number
YU195383A
YU195383A YU01953/83A YU195383A YU195383A YU 195383 A YU195383 A YU 195383A YU 01953/83 A YU01953/83 A YU 01953/83A YU 195383 A YU195383 A YU 195383A YU 195383 A YU195383 A YU 195383A
Authority
YU
Yugoslavia
Prior art keywords
tetrapeptide
alkylamide
making
active tripeptide
biologicaly active
Prior art date
Application number
YU01953/83A
Other languages
English (en)
Inventor
E Kasafirek
P Fric
J Slaby
A Roubalova
Original Assignee
Spofa Vereinigte Pharma Werke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spofa Vereinigte Pharma Werke filed Critical Spofa Vereinigte Pharma Werke
Publication of YU195383A publication Critical patent/YU195383A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1021Tetrapeptides with the first amino acid being acidic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
YU01953/83A 1982-10-01 1983-09-29 Process for making biologicaly active tripeptide tetrapeptide alkylamide YU195383A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS827013A CS231228B1 (en) 1982-10-01 1982-10-01 Biologically effective tri and tetrapeptide alkylamide derivatives and their processing method

Publications (1)

Publication Number Publication Date
YU195383A true YU195383A (en) 1986-08-31

Family

ID=5418471

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01953/83A YU195383A (en) 1982-10-01 1983-09-29 Process for making biologicaly active tripeptide tetrapeptide alkylamide

Country Status (13)

Country Link
US (1) US4528133A (fr)
JP (1) JPS5978150A (fr)
BE (1) BE897844A (fr)
CA (1) CA1243306A (fr)
CH (1) CH658251A5 (fr)
CS (1) CS231228B1 (fr)
DE (1) DE3335865A1 (fr)
FR (1) FR2533920B1 (fr)
GB (1) GB2127830B (fr)
HU (1) HU193048B (fr)
IT (1) IT1171092B (fr)
SE (1) SE457087B (fr)
YU (1) YU195383A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444042A (en) * 1990-12-28 1995-08-22 Cortex Pharmaceuticals Method of treatment of neurodegeneration with calpain inhibitors
IL108031A0 (en) * 1992-12-22 1994-04-12 Procter & Gamble Difluoro pentapeptide derivatives and pharmaceutical compositions containing them
CZ285911B6 (cs) * 1997-04-30 1999-11-17 Vúfb, A. S. Oligopeptidické inhibitory elastáz
JP2000256396A (ja) 1999-03-03 2000-09-19 Dainippon Pharmaceut Co Ltd 複素環式化合物およびその中間体ならびにエラスターゼ阻害剤
MXPA02001349A (es) * 1999-08-09 2002-07-22 Tripep Ab Inhibidores de la polimerizacion de proteinas y metodos de uso.
AU7549100A (en) 1999-10-18 2001-04-30 Firmenich S.A. Esters comprising a secondary carbamoyl function and their use as odorant alcohol precursors
US6593455B2 (en) * 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
EP1436317A1 (fr) * 2001-09-19 2004-07-14 Tripep Ab Molecules bloquant l'infectivite virale et methodes d'utilisation associees
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
KR20050101221A (ko) * 2003-02-21 2005-10-20 트리펩 아베 Hiv 복제의 억제를 위한 글리신아미드 유도체
WO2016044400A1 (fr) * 2014-09-16 2016-03-24 Massachusetts Institute Of Technology Micelles à noyau de coacervat complexe à copolymère bloc pour la catalyse enzymatique dans un solvant organique
EP3472179A1 (fr) 2016-06-17 2019-04-24 Erasmus University Medical Center Rotterdam Composés géminoïdes lipopeptides et leurs utilisations
WO2022235051A1 (fr) 2021-05-03 2022-11-10 한국화학연구원 Agent d'extraction et procédé d'extraction pour l'élimination de substances étrangères conférant de la couleur d'un polymère coloré contenant un groupe fonctionnel ester et procédé pour la sélection chimique d'un polymère contenant un groupe fonctionnel ester à partir d'un mélange à base de polymère coloré

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3972773A (en) * 1975-04-29 1976-08-03 Sagami Chemical Research Center Process for producing peptide
CH627735A5 (de) * 1976-06-25 1982-01-29 Hoffmann La Roche Verfahren zur herstellung von dipeptidderivaten.
US4167449A (en) * 1976-07-29 1979-09-11 American Hospital Supply Corporation Composition and method for determining transferase and protease activity
US4155916A (en) * 1977-08-29 1979-05-22 Dolbeare Frank A Fluorescence method for enzyme analysis which couples aromatic amines with aromatic aldehydes
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US4336186A (en) * 1978-08-03 1982-06-22 Gargiulo Robert J Analytical fluorogenic substrates for proteolytic enzymes
US4275153A (en) * 1978-08-03 1981-06-23 American Hospital Supply Corporation Analytical fluorogenic substrates for proteolytic enzymes
CS226907B1 (en) * 1981-08-07 1984-04-16 Kasafirek Evzen Alkylamides of carboxyalkanoylpeptides
US4371466A (en) * 1981-10-07 1983-02-01 American Home Products Corporation Mammalian collagenase inhibitors

Also Published As

Publication number Publication date
SE8305123D0 (sv) 1983-09-22
GB2127830B (en) 1986-08-13
US4528133A (en) 1985-07-09
FR2533920A1 (fr) 1984-04-06
GB2127830A (en) 1984-04-18
CS231228B1 (en) 1984-10-15
IT8323059A1 (it) 1985-03-29
JPH0359919B2 (fr) 1991-09-12
JPS5978150A (ja) 1984-05-04
CA1243306A (fr) 1988-10-18
DE3335865C2 (fr) 1991-03-14
SE457087B (sv) 1988-11-28
HU193048B (en) 1987-08-28
IT1171092B (it) 1987-06-10
IT8323059A0 (it) 1983-09-29
SE8305123L (sv) 1984-04-02
BE897844A (fr) 1984-01-16
CH658251A5 (de) 1986-10-31
FR2533920B1 (fr) 1986-08-14
GB8324970D0 (en) 1983-10-19
DE3335865A1 (de) 1984-04-05

Similar Documents

Publication Publication Date Title
DE3377506D1 (en) Process for obtaining pancreatin
EP0114993A3 (en) Renin inhibitory tripeptides
YU195383A (en) Process for making biologicaly active tripeptide tetrapeptide alkylamide
GB8333460D0 (en) Peptide substrates
ZA841567B (en) Pharmacologically active tripeptide derivatives
GB8312339D0 (en) Peptides
YU249081A (en) Process for obtaining pharmacologically active peptides
DE3361649D1 (en) Process for synthesizing peptides or peptide derivatives
GB8415884D0 (en) Peptides
GB8323909D0 (en) Peptides
DE3379506D1 (en) Process for producing peptide
GB2130220B (en) Pharmacologically active peptides
PL246597A1 (en) Process for preparing peptides
PT76676B (en) Method for spray drying dipeptide sweeteners
DE3461092D1 (en) Peptides
PT76904B (en) Process for sweetner solution purification
PT78657B (en) Process for preparing aspartame
PL243972A1 (en) Process for preparing l-phenylalanine
EP0121995A3 (en) Peptides
GB2136436B (en) Pharmacologically active tripeptide derivatives
PT76790B (en) Process for preparing carboxyalkyl dipeptides
GB8316296D0 (en) Peptides
IE821552L (en) Dipeptide
AU7455781A (en) Tripeptide alkylamide derivatives
GB8334365D0 (en) Phosphorous containing peptides